Milestone Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
/ 
Frequently asked questions
To buy Milestone Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Milestone Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Milestone Pharmaceuticals Inc. is MIST:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Milestone Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Milestone Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Milestone Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Milestone Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Milestone Pharmaceuticals Inc..